Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin and Diphenhydramine for Nighttime Pruritus in Atopic Dermatitis
NCT03688464Phase 1Withdrawn
- Sponsor
- University of Nebraska
- Start
- Feb 2019
- Primary completion
- Feb 2019
01
Overview
Phase 1, randomised, double-blind trial of melatonin in atopic dermatitis (AD) (3 arms), sponsored by University of Nebraska. Primary endpoints: Patient Oriented Eczema Measure at 6 weeks and Eczema Area and Severity Index at 6 weeks. Planned start Feb 2019; status: withdrawn.
02
Drugs
melatonin
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT03688464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03688464.